You are here : Home > Research entities > DMTS > Molecular engineering for Heal ... > Selected publications (2021-2011) of the team "Chemical modifications of proteins"

Selected publications (2021-2011) of the team "Chemical modifications of proteins"

Published on 29 April 2022
  • Targeting Out of Range Biomolecules: Chemical Labeling Strategies for Qualitative and Quantitative MALDI MS-based Detection. M. Sejalon-Cipolla, .Bruyat, S.Bregant, C.Malgorn, L.Devel, G.Subra, S.Cantel, TrAC Trends in Analytical Chemistry, 2021, Available online 24 July 2021, 116399.
  • Ligand-directed modification of active Matrix Metalloproteases: New activity-based probes with no photolabile group. Kaminska M, Bruyat P, Malgorn C, Doladilhe M, Cassar-Lajeunesse E, Fruchart C, De Souza M, Beau F, Thai R, Correia I, Galat A, Georgiadis D, Lequin O, Dive V, Bregant S. Devel L.* Angew Chem Int Ed Engl. 2021 Jun 7. doi: 10.1002/anie.202106117
  • Analytical Methods for the Detection and Quantification of ADCs in Biological Matrices, Héloïse Cahuzac and Laurent Devel*. Pharmaceuticals 2020, 13(12), 462; (registering DOI) - 14 Dec 2020.
  • Hydroxamate based Selective Macrophage Elastase (MMP-12) Inhibitors and Radiotracers for Molecular Imaging, Gona K, Toczek J, Ye Y, Sanzida N, Golbazi A, Boodagh P, Salarian M, Jung JJ, Rajendran S, Kukreja G, Wu TL, Devel L, Sadeghi MM* J Med Chem. 2020, 3(23):15037-15049. doi: 10.1021/acs.jmedchem.0c01514. Epub 2020 Nov 18.
  • Novel Matrix Metalloproteinase 12 selective radiotracers for vascular molecular imaging. Toczek J, Bordenave T, Gona K, Kim HY, Beau F, Georgiadis D, Correia I, Yunpeng Y, Razavian M, Jung J, Lequin O, Dive V, Sadeghi MM, Devel L*. J Med Chem. 2019 Oct 11. doi: 10.1021/acs.jmedchem.9b01186.
  • Biodistribution of nanostructured lipid carriers in mice atherosclerotic model, Laurent Devel, Gunter Almer, Claudia Cabella, Fabrice Beau, Mylène Bernes, Paolo Oliva, Fabrice Navarro, Ruth Prassl, Harald Mangge, Isabelle Texier, Molecules, 2019 Sep 26;24(19):3499. doi: 10.3390/molecules24193499.
  • Synthesis and structural/functional characterization of selective M14 metallo-carboxypeptidase inhibitors based on phosphinic pseudo peptide scaffold: Implications on the design of specific optical probes. Covaleda G, Gallego P, Vendrell J, Georgiadis D, Lorenzo J, Dive V, Aviles FX, Reverter D, Devel L*. J Med Chem. 2019 Feb 28;62(4):1917-1931. IF=6.2
  • Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity. Rouanet-Mehouas C, Czarny B, Beau F, Cassar-Lajeunesse E, Stura EA, Dive V, Devel L*. J. Med. Chem. 2017, 60 (1), p 403-414. IF=6.2
  • Optical imaging of MMP-12 active form in inflammation and aneurysm. Razavian M, Bordenave T, Georgiadis D, Beau F, Zhang J, Golestani R, Toczek J, Jung JJ, Ye Y, Kim HY, Han J, Dive V, Devel L, Sadeghi MM. Sci Rep. 2016, Dec 5; 6 :38345. IF=4.2
  • Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes. Bordenave T, Helle M, Beau F, Georgiadis D, Tepshi L, Bernes M, Ye Y, Levenez L, Poquet E, Nozach H, Razavian M, Toczek J, Stura EA, Dive V, Sadeghi MM, Devel L*. Bioconjugate Chemistry. 2016, 27(10), p 2407-2417.
  • A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Marchant DJ, Bellac CL, Moraes TJ, Wadsworth SJ, Dufour A, Butler GS, Bilawchuk LM, Hendry RG, Robertson AG, Cheung CT, Ng J, Ang L, Luo Z, Heilbron K, Norris MJ, Duan W, Bucyk T, Karpov A, Devel L, Georgiadis D, Hegele RG, Luo H, Granville DJ, Dive V, McManus BM, Overall CM. Nat Med. 2014, 20(5), p 493-502.
  • Effects of selective MMP-13 inhibition in squamous cell carcinoma depend on estrogen. Meides A, Gutschalk CM, Devel L, Beau F, Czarny B, Hensler S, Neugebauer J, Dive V, Angel P, Mueller MM. Int J Cancer. 2014, 135(12). p 2749-59.
  • In vivo imaging of matrix metalloproteinase 12 and matrix metalloproteinase 13 activities in the mouse model of collagen-induced arthritis. Lim NH, Meinjohanns E, Bou-Gharios G, Gompels LL, Nuti E, Rossello A, Devel L, Dive V, Meldal M, Nagase H. Arthritis & Rheumatol. 2014, 66(3), p 589-98.
  • Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors? Torkar A, Lenarčič B, Lah T, Dive V, Devel L*. Bioorg. Med. Chem. Lett. 2013, 23(10), p 2968-73.
  • Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies. Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V. J. Med. Chem. 2013, 14, 56(3), p 1149-59.
  • Simple pseudo dipeptides with a P2' glutamate: a novel inhibitor family of MMPs and other metzincins. Devel L*, Beau F, Amoura M, Vera L, Cassar-Lajeunesse E, Garcia S, Czarny B, Stura EA, Dive V. J. Biol. Chem. 2012, 287(32), p 26647-56.
  • A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice. Johnson JL, Devel L, Czarny B, George SJ, Jackson CL, Rogakos V, Beau F, Yiotakis A, Newby AC, Dive V. Arterioscler. Thromb. Vasc. Biol. 2011, 31(3), p 528-35